Zhejiang Shapuaisi Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Shapuaisi Pharmaceutical Co Ltd financial flexibility index. Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥43.41 Million (operating CF CN¥8.57 Million minus capex CN¥34.84 Million) represents 0% of total liabilities (CN¥513.25 Million). See how much free cash does Zhejiang Shapuaisi Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Financial flexibility index of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. Historical Financial Flexibility Index trend for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Financial Flexibility Index by Year (2008–2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 603168 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥153.78 Million | CN¥25.67 Million | CN¥516.59 Million | ▼ -49.8% |
| 2023 | 0.59x | CN¥261.29 Million | CN¥41.49 Million | CN¥440.92 Million | ▼ -46.0% |
| 2022 | 1.10x | CN¥264.41 Million | CN¥115.72 Million | CN¥240.99 Million | ▲ +0.5% |
| 2021 | 1.09x | CN¥254.23 Million | CN¥100.78 Million | CN¥232.89 Million | ▲ +553.5% |
| 2020 | 0.17x | CN¥61.27 Million | CN¥44.09 Million | CN¥366.78 Million | ▼ -79.0% |
| 2019 | 0.80x | CN¥79.80 Million | CN¥59.47 Million | CN¥100.28 Million | ▼ -16.1% |
| 2018 | 0.95x | CN¥158.75 Million | CN¥100.37 Million | CN¥167.41 Million | ▲ +26.1% |
| 2017 | 0.75x | CN¥159.57 Million | CN¥45.57 Million | CN¥212.13 Million | ▼ -44.2% |
| 2016 | 1.35x | CN¥334.27 Million | CN¥294.33 Million | CN¥247.88 Million | ▲ +143.6% |
| 2015 | 0.55x | CN¥212.21 Million | CN¥114.27 Million | CN¥383.37 Million | ▼ -75.8% |
| 2014 | 2.29x | CN¥250.52 Million | CN¥147.99 Million | CN¥109.44 Million | ▲ +194.9% |
| 2013 | 0.78x | CN¥189.59 Million | CN¥117.86 Million | CN¥244.26 Million | ▲ +35.1% |
| 2012 | 0.57x | CN¥139.18 Million | CN¥67.27 Million | CN¥242.33 Million | ▲ +61.0% |
| 2011 | 0.36x | CN¥44.74 Million | CN¥15.14 Million | CN¥125.43 Million | ▼ -1.9% |
| 2010 | 0.36x | CN¥25.62 Million | CN¥17.57 Million | CN¥70.45 Million | ▼ -24.9% |
| 2009 | 0.48x | CN¥37.36 Million | CN¥28.87 Million | CN¥77.15 Million | ▲ +38.5% |
| 2008 | 0.35x | CN¥24.21 Million | CN¥11.20 Million | CN¥69.24 Million | — |